176 related articles for article (PubMed ID: 17255943)
1. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
2. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
Onodera Y; Hashimoto S; Hashimoto A; Morishige M; Mazaki Y; Yamada A; Ogawa E; Adachi M; Sakurai T; Manabe T; Wada H; Matsuura N; Sabe H
EMBO J; 2005 Mar; 24(5):963-73. PubMed ID: 15719014
[TBL] [Abstract][Full Text] [Related]
3. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.
Haglund K; Shimokawa N; Szymkiewicz I; Dikic I
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12191-6. PubMed ID: 12218189
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
5. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.
Morishige M; Hashimoto S; Ogawa E; Toda Y; Kotani H; Hirose M; Wei S; Hashimoto A; Yamada A; Yano H; Mazaki Y; Kodama H; Nio Y; Manabe T; Wada H; Kobayashi H; Sabe H
Nat Cell Biol; 2008 Jan; 10(1):85-92. PubMed ID: 18084281
[TBL] [Abstract][Full Text] [Related]
6. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
7. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
8. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.
Hashimoto S; Hirose M; Hashimoto A; Morishige M; Yamada A; Hosaka H; Akagi K; Ogawa E; Oneyama C; Agatsuma T; Okada M; Kobayashi H; Wada H; Nakano H; Ikegami T; Nakagawa A; Sabe H
Proc Natl Acad Sci U S A; 2006 May; 103(18):7036-41. PubMed ID: 16636290
[TBL] [Abstract][Full Text] [Related]
9. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
Lizárraga F; Poincloux R; Romao M; Montagnac G; Le Dez G; Bonne I; Rigaill G; Raposo G; Chavrier P
Cancer Res; 2009 Apr; 69(7):2792-800. PubMed ID: 19276357
[TBL] [Abstract][Full Text] [Related]
10. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
Bowden ET; Barth M; Thomas D; Glazer RI; Mueller SC
Oncogene; 1999 Aug; 18(31):4440-9. PubMed ID: 10442635
[TBL] [Abstract][Full Text] [Related]
11. GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.
Hashimoto A; Hashimoto S; Ando R; Noda K; Ogawa E; Kotani H; Hirose M; Menju T; Morishige M; Manabe T; Toda Y; Ishida S; Sabe H
PLoS One; 2011; 6(8):e23359. PubMed ID: 21858086
[TBL] [Abstract][Full Text] [Related]
12. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
Onodera Y; Nam JM; Hashimoto A; Norman JC; Shirato H; Hashimoto S; Sabe H
J Cell Biol; 2012 Jun; 197(7):983-96. PubMed ID: 22734003
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy.
Samoylenko A; Vynnytska-Myronovska B; Byts N; Kozlova N; Basaraba O; Pasichnyk G; Palyvoda K; Bobak Y; Barska M; Mayevska O; Rzhepetsky Y; Shuvayeva H; Lyzogubov V; Usenko V; Savran V; Volodko N; Buchman V; Kietzmann T; Drobot L
Carcinogenesis; 2012 Oct; 33(10):1976-84. PubMed ID: 22791810
[TBL] [Abstract][Full Text] [Related]
14. Adaptor protein Ruk/CIN85 is associated with a subset of COPI-coated membranes of the Golgi complex.
Havrylov S; Ichioka F; Powell K; Borthwick EB; Baranska J; Maki M; Buchman VL
Traffic; 2008 May; 9(5):798-812. PubMed ID: 18266907
[TBL] [Abstract][Full Text] [Related]
15. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
16. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
17. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.
Sabe H; Hashimoto S; Morishige M; Ogawa E; Hashimoto A; Nam JM; Miura K; Yano H; Onodera Y
Traffic; 2009 Aug; 10(8):982-93. PubMed ID: 19416474
[TBL] [Abstract][Full Text] [Related]
18. Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.
Yoshio T; Morita T; Kimura Y; Tsujii M; Hayashi N; Sobue K
FEBS Lett; 2007 Aug; 581(20):3777-82. PubMed ID: 17631293
[TBL] [Abstract][Full Text] [Related]
19. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
[TBL] [Abstract][Full Text] [Related]
20. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
